Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-18

Clinical Trial Update: Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Lipiflow treatment alone versus Lipiflow plus Dextenza for dry eye disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)
  • LipiFlow

Snippet

Sponsor: Eye Surgeons of Indiana | Conditions: Dry Eye Syndromes | Phase 4 | Status: COMPLETED